Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12099759 | 0.89 | EPHX1 (0.32) | TSHRMAPK1POLBHSD17B10MEN1 | |
| SCHEMBL12456866 | 0.88 | TSHR (0.33) | TSHRMAPK1 | |
| SCHEMBL25938003 | 0.88 | TSHR (0.31) | TSHRPOLBHSD17B10MEN1KMT2A | |
| SCHEMBL214325 | 0.86 | TSHR (0.32) | TSHRPOLBHSD17B10MEN1KMT2A | |
| SCHEMBL26073685 | 0.85 | TSHR (0.35) | TSHRPOLBHSD17B10MEN1KMT2A | |
| SCHEMBL14168972 | 0.85 | TSHR (0.30) | TSHR | |
| SCHEMBL13219673 | 0.84 | TSHR (0.31) | TSHRPOLBHSD17B10MEN1KMT2A | |
| SCHEMBL439901 | 0.83 | TSHR (0.36) | TSHRPOLBHSD17B10MEN1KMT2A | |
| SCHEMBL14168875 | 0.82 | TSHR (0.31) | TSHR | |
| SCHEMBL213181 | 0.82 | MEN1 (0.32) | TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12421337-B2 | Resin composition and cured film | ECHEM SOLUTIONS CORP. (TW) | 2025-09-23 | — | — | US | disclosed |
| CN-115895313-B | Resin composition and cured film | 新应材股份有限公司 | 2024-05-10 | — | — | CN | disclosed |
| US-11958971-B2 | Photocurable composition, method for producing concave-convex structure, method for forming fine concave-convex pattern, and concave-convex structure | MITSUI CHEMICALS, INC. (JP) | 2024-04-16 | — | — | US | disclosed |
| CN-110741463-B | Method for producing substrate with fine concave-convex pattern, resin composition, and laminate | 三井化学株式会社 | 2024-02-20 | — | — | CN | disclosed |
| US-11886119-B2 | Material for forming underlayer film, resist underlayer film, method of producing resist underlayer film, and laminate | MITSUI CHEMICALS, INC. (JP) | 2024-01-30 | — | — | US | disclosed |
| CN-110709774-B | Underlayer film forming material, resist underlayer film, method for producing resist underlayer film, and laminate | 三井化学株式会社 | 2023-12-08 | — | — | CN | disclosed |
| CN-113574086-B | Photocurable composition, method for producing uneven structure, method for forming fine uneven pattern, and uneven structure | 三井化学株式会社 | 2023-11-07 | — | — | CN | disclosed |
| US-20230303761-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, LENS, AND LENS WITH A SUBSTRATE | AGC Inc. (JP) | 2023-09-28 | — | — | US | disclosed |
| CN-116529282-A | Curable resin composition, cured product, lens, and lens with substrate | ＡＧＣ株式会社 | 2023-08-01 | — | — | CN | disclosed |
| US-20230185195-A1 | MATERIAL FOR FORMING UNDERLAYER FILM, RESIST UNDERLAYER FILM, METHOD OF PRODUCING RESIST UNDERLAYER FILM, AND LAMINATE | MITSUI CHEMICALS, INC. (JP) | 2023-06-15 | — | — | US | disclosed |
| US-20080146777-A1 | Composition that is Curable Cationic Polymerization Initiated by Active Energy Beam and Image Forming Method Using the Composition | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-06-19 | — | — | US | disclosed |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-05-08 | — | — | US | disclosed |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-05-08 | — | — | US | disclosed |
| US-7360883-B2 | Active ray curable ink, image forming method and ink-jet recording apparatus | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-04-22 | — | — | US | disclosed |
| US-7360883-B2 | Active ray curable ink, image forming method and ink-jet recording apparatus | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-04-22 | — | — | US | disclosed |
| EP-1840148-A1 | POLYMERIZABLE ACTINIC RADIATION CURABLE COMPOSITION, POLYMERIZATION METHOD, ACTINIC RADIATION CURABLE INK AND IMAGE FORMATION METHOD, AND INK JET RECORDING APPARATUS AND EPOXY COMPOUND | Konica Minolta Medical & Graphic, Inc. (JP) | 2007-10-03 | — | — | EP | disclosed |
| EP-1837357-A1 | ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, METHOD OF IMAGE FORMING THEREWITH, INKJET RECORDING APPARATUS AND EPOXY COMPOUND | Konica Minolta Medical & Graphic, Inc. (JP) | 2007-09-26 | — | — | EP | disclosed |
| US-20070219292-A1 | INK SET FOR INK-JET RECORDING, POLYMERIZATION METHOD AND IMAGE FORMING METHOD | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070219292-A1 | INK SET FOR INK-JET RECORDING, POLYMERIZATION METHOD AND IMAGE FORMING METHOD | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-09-20 | — | — | US | disclosed |
| EP-1829936-A1 | ACTIVE RAY-CURABLE COMPOSITION, ACTIVE RAY-CURABLE INK AND IMAGE-FORMING METHOD | Konica Minolta Medical & Graphic, Inc. (JP) | 2007-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | CBR3, CBR1, CNR1 | TSHR 2029/4885MAPK1 1476/4885POLB 1287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.